Advertisement

Topics

Search Results for "Metformin Hidradenitis"

09:46 EDT 24th May 2016 | BioPortfolio

Matching Channels

Matching News

Avalon, TPG Lead $15M Deal to Advance Metformin as Cancer Drug

Metformin has long been the first-line drug of choice for treating type 2 diabetes. While insulin may be better known (it’s been available since the 1920s), metformin was introduced in the UK in 195...

Smoking, age, care type may be factors with hidradenitis suppurativa treatment

The likelihood of receiving or escalating treatment for hidradenitis suppurativa was associated with clinician type, tobacco smoking and age, according to study results published in JAMA Dermatology.R...

Hidradenitis suppurativa associated with significant cardiovascular risk

Patients with hidradenitis suppurativa had a significantly increased risk for adverse cardiovascular outcomes and all-cause mortality, according to study results in JAMA Dermatology.Researchers in Den...

Anakinra Shows Promise in Hidradenitis Suppurativa

Anakinra reduced disease activity in two thirds of patients with hidradenitis suppurativa, although it is unclear how to determine which patients would be most likely to benefit. Medscape Medical Ne...

UK NICE recommends Humira as treatment for hidradenitis suppurativa

The National Institute for Health and Care Excellence (NICE) has recommended the use of biopharmaceutical company AbbVie's Humira (adalimumab) for treatment of hidradenitis suppurativa (HS) in adults.

Vitamin B12 deficiency seen with long-term metformin use

Biochemical vitamin B12 deficiency and anemia were associated with long-term use of metformin, according to findings from the Diabetes Prevention Program Outcomes Study. Jill P. Crandall, MD, professo...

Metformin Active in Reducing Colorectal Polyp Recurrence

Dr David Kerr reports on a randomized study in which low-dose metformin reduced recurrence of colorectal polyps from 56% to 38%. Is metformin potentially another strategy to prevent colorectal cancer?...

Metformin-containing Drugs: Drug Safety Communication - Revised Warnings for Certain Patients With Reduced Kidney Function

Audience: Pharmacy, Nephrology, Internal Medicine, Patient ISSUE: FDA is requiring labeling changes regarding the recommendations for metformin-containing medicines for diabetes to expand metformin’...

Matching PubMed Articles

Update on Hidradenitis Suppurative (Part II): Treatment.

Although hidradenitis suppurativa is a common and serious skin condition, its treatment is not well established. It is now accepted that the moderate and severe forms of the disease are associated wit...

Prevalence and predictors of metformin prescribing in adults with type 2 diabetes mellitus: a national cross sectional study.

Metformin is the first-line oral type 2 diabetes treatment. Despite an abundance of evidence, metformin is routinely under-utilized. This study evaluated the rates of metformin usage in an approp...

An Update on Hidradenitis Suppurativa (Part I): Epidemiology, Clinical Aspects, and Definition of Disease Severity.

Hidradenitis suppurativa is a chronic inflammatory disorder that has attracted increasing attention in recent years due to underestimations of prevalence and the considerable impact of the condition o...

Metformin and the gastrointestinal tract.

Metformin is an effective agent with a good safety profile that is widely used as a first-line treatment for type 2 diabetes, yet its mechanisms of action and variability in terms of efficacy and side...

Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 2: Treatment Options.

To provide an overview of treatment recommendations for hidradenitis suppurativa (HS).

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement